Godrej Consumer Products Ltd
Godrej Consumer Products Ltd
Consumer Goods F&OKey Fundamentals
MidcapPersonal CareConsumer GoodsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Godrej Consumer Products Ltd insights
48 extracted metrics + investor summaries across FY05–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
4- Stock is trading at 7.56 times its book value
- The company has delivered a poor sales growth of 6.60% over past five years.
- Company has a low return on equity of 13.8% over last 3 years.
- Promoter holding has decreased over last 3 years: -10.2%
Growth Rate
AI Analysis — Bull vs Bear
Godrej Consumer Products Ltd has a market cap of ₹95,458 Cr and trades at a PE of 49.8x with a TTM sales growth of 9% and profit growth of 9%. The stock has underperformed with a 1-year return of -21% while ROE stands at 16% for the last year, and promoter holding has declined by 10.2% over 3 years.
- TTM revenue growth has accelerated to 9%, above the 5-year compounded sales CAGR of 7% and 3-year CAGR of 4%, indicating improving top-line momentum
- TTM profit growth of 9% is the highest recent period, outpacing the 5-year compounded profit CAGR of 3%, suggesting margin recovery
- Last year ROE of 16% is above the 3-year average of 14% and 5-year average of 14%, showing improving capital efficiency
- 10-year compounded sales CAGR of 6% and profit CAGR of 6% demonstrate long-term consistency in a consumer staples business with recurring demand
- Market cap of ₹95,458 Cr reflects large-cap status with established brand portfolio across home and personal care categories, providing business stability
- Dividend yield of 0.53% provides a small but consistent income component, typical for reinvestment-focused FMCG companies
- Stock price decline of -21% over 1 year against improving TTM fundamentals (9% sales and profit growth) may indicate valuation compression from elevated levels
- PE ratio of 49.8x is significantly elevated for a company delivering only 9% TTM profit growth, implying a PEG ratio above 5x
- Price-to-book ratio of 7.54x is high, indicating the stock trades at a steep premium to its net asset value
- Promoter holding has decreased by 10.2% over the last 3 years, signaling reduced insider confidence or strategic dilution
- 5-year compounded sales CAGR of only 7% and 3-year sales CAGR of just 4% reflect sluggish revenue growth for an FMCG business
- 5-year compounded profit CAGR of just 3% significantly trails revenue growth, indicating margin pressures over the medium term
- 3-year ROE average of 14% is below the 10-year average of 18%, suggesting structural deterioration in return generation
- Stock CAGR of -3% over 3 years and -1% over 5 years shows the stock has destroyed value for medium-term holders despite being in a defensive sector
- 10-year stock CAGR of only 6% barely matches the compounded profit growth of 6%, offering no re-rating benefit over a full market cycle
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- HSBC downgrades on CEO exit Aug 12
HSBC downgraded GCPL to Hold with target cut to ₹1,120, reducing target P/E from 45x to 40x citing execution uncertainty after Sudhir Sitapati's sudden departure.
- Q1 profit misses estimate Aug 7
Q1 net profit of ₹5.04B came in below the ₹5.3B estimate, and revenue of ₹42.2B slightly missed the ₹42.5B consensus.
- Cash constraints acknowledged Aug 10
Management acknowledged cash constraints as a factor, with EBITDA and volume target beats contingent on commodity trends.
- New CEO; FY27 guidance reaffirmed Aug 14
Aasif Malbari appointed MD & CEO effective Aug 12, 2026. Management reaffirmed FY27 guidance of high-single-digit volume growth and double-digit revenue/profit growth. Africa EBITDA margins grew from ~9% in FY24 to ~15% in FY26 under his leadership.
- Citi and Jefferies retain Buy Aug 12
Citi maintains Buy with ₹1,350 target citing continuity; Jefferies retains Buy at ₹1,400 target pointing to HI/soaps recovery and volume-led growth.
- India volume growth at 8% Aug 10
GCPL projected India volume growth at 8% for the year and expressed confidence in meeting full-year revenue growth targets.
- Q1 EBITDA beats estimates Aug 7
Q1 EBITDA rose to ₹8B from ₹6.94B YoY, beating the ₹7.85B estimate, with margin steady at 18.96% vs 18.5% expected.
- ₹200 Cr pet care investment Jul 22
GCPL invested ₹200 Cr in its 100%-owned Godrej Pet Care subsidiary via rights issue to fund growth in new category.
- ₹5 interim dividend declared Aug 7
Board declared ₹5 per share interim dividend for FY27 with record date of August 13, 2026.
- Sitapati reappointed at AGM Aug 7
Shareholders approved Sudhir Sitapati's 5-year reappointment as MD & CEO at the 26th AGM on Aug 7, though he subsequently departed days later.
- Q1FY27 earnings call released Aug 7
Audio recording of Q1FY27 earnings conference call held Aug 7 made available on company website.
- Investor call on Aug 11 Aug 11
GCPL hosted a virtual conference call for institutional investors on Aug 11 from 5:30-6:30 PM IST to address leadership transition.
TL;DR: GCPL delivered a mixed Q1 with EBITDA beating estimates but profit missing consensus. The abrupt CEO transition from Sitapati to Malbari introduces near-term execution uncertainty, though management has reaffirmed FY27 guidance of high-single-digit volume growth and double-digit profit growth. India volume growth projected at 8% and margin discipline remain positives. The key risk is whether leadership continuity holds under the new CEO — trend is stable but sentiment depends on execution proof points in coming quarters.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,449 | 3,602 | 3,660 | 3,386 | 3,332 | 3,666 | 3,768 | 3,514 | 3,662 | 3,825 | 3,998 | 3,900 | 4,225 |
| Expenses | 2,806 | 2,898 | 2,819 | 2,630 | 2,607 | 2,907 | 3,012 | 2,755 | 2,967 | 3,092 | 3,118 | 3,059 | 3,424 |
| Operating Profit | 643 | 704 | 841 | 756 | 724 | 760 | 756 | 759 | 695 | 733 | 880 | 841 | 801 |
| OPM % | 19% | 20% | 23% | 22% | 22% | 21% | 20% | 22% | 19% | 19% | 22% | 22% | 19% |
| Other Income | -13 | 53 | 63 | -2,312 | 57 | 80 | 77 | 42 | 65 | 33 | -35 | -24 | 36 |
| Interest | 74 | 77 | 67 | 78 | 88 | 83 | 90 | 90 | 86 | 76 | 79 | 90 | 86 |
| Depreciation | 76 | 61 | 54 | 50 | 49 | 50 | 62 | 73 | 59 | 66 | 66 | 76 | 75 |
| PBT | 480 | 619 | 783 | -1,684 | 644 | 707 | 682 | 639 | 614 | 625 | 700 | 651 | 677 |
| Tax % | 34% | 30% | 26% | 12% | 30% | 30% | 27% | 36% | 26% | 27% | 29% | 31% | 25% |
| Net Profit | 319 | 433 | 581 | -1,893 | 451 | 491 | 498 | 412 | 452 | 459 | 498 | 452 | 505 |
| EPS in Rs | 3.12 | 4.23 | 5.68 | -18.51 | 4.41 | 4.8 | 4.87 | 4.03 | 4.42 | 4.49 | 4.87 | 4.42 | 4.93 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,273 | 8,424 | 9,268 | 9,847 | 10,314 | 9,911 | 11,029 | 12,276 | 13,316 | 14,096 | 13,997 | 15,178 | 15,949 |
| Expenses | 6,894 | 6,766 | 7,361 | 7,763 | 8,183 | 7,757 | 8,629 | 9,867 | 10,873 | 11,139 | 10,982 | 12,009 | 12,692 |
| Operating Profit | 1,379 | 1,657 | 1,907 | 2,084 | 2,132 | 2,154 | 2,399 | 2,409 | 2,443 | 2,957 | 3,015 | 3,169 | 3,257 |
| OPM % | 17% | 20% | 21% | 21% | 21% | 22% | 22% | 20% | 18% | 21% | 22% | 21% | 20% |
| Other Income | 73 | -262 | 76 | 283 | 362 | 32 | 23 | 78 | 114 | -2,209 | 252 | 33 | 11 |
| Interest | 112 | 128 | 154 | 173 | 238 | 228 | 138 | 122 | 188 | 310 | 361 | 344 | 331 |
| Depreciation | 91 | 101 | 142 | 156 | 170 | 197 | 204 | 210 | 236 | 241 | 234 | 268 | 283 |
| PBT | 1,249 | 1,167 | 1,687 | 2,039 | 2,085 | 1,760 | 2,080 | 2,155 | 2,133 | 198 | 2,672 | 2,590 | 2,653 |
| Tax % | 22% | 29% | 22% | 20% | -12% | 15% | 17% | 17% | 20% | 383% | 31% | 28% | — |
| Net Profit | 976 | 831 | 1,308 | 1,634 | 2,342 | 1,497 | 1,721 | 1,783 | 1,702 | -561 | 1,852 | 1,861 | 1,914 |
| EPS in Rs | 8.88 | 8.1 | 12.76 | 15.99 | 22.91 | 14.64 | 16.83 | 17.44 | 16.65 | -5.48 | 18.11 | 18.19 | 18.71 |
| Div. Payout % | 21% | 24% | 39% | 42% | 44% | 55% | 0% | 0% | 0% | -274% | 138% | 110% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 34 | 34 | 34 | 68 | 102 | 102 | 102 | 102 | 102 | 102 | 102 | 102 |
| Reserves | 4,277 | 4,233 | 5,268 | 6,190 | 7,165 | 7,796 | 9,337 | 11,454 | 13,692 | 12,496 | 11,897 | 12,546 |
| Borrowings | 2,717 | 2,891 | 4,001 | 3,508 | 3,382 | 3,575 | 1,864 | 1,704 | 1,130 | 3,222 | 4,009 | 4,421 |
| Other Liabilities | 2,097 | 2,521 | 3,637 | 4,098 | 3,445 | 3,407 | 2,941 | 2,822 | 2,513 | 2,571 | 3,289 | 3,873 |
| Total Liabilities | 9,125 | 9,679 | 12,940 | 13,864 | 14,094 | 14,880 | 14,244 | 16,082 | 17,437 | 18,392 | 19,298 | 20,942 |
| Fixed Assets | 5,551 | 5,931 | 8,083 | 8,315 | 8,670 | 9,231 | 8,905 | 9,219 | 9,934 | 10,440 | 10,676 | 12,556 |
| CWIP | 225 | 44 | 97 | 84 | 52 | 57 | 57 | 116 | 45 | 83 | 464 | 229 |
| Investments | 186 | 190 | 934 | 997 | 516 | 672 | 679 | 1,015 | 3,029 | 3,504 | 3,645 | 2,767 |
| Other Assets | 3,164 | 3,514 | 3,826 | 4,468 | 4,855 | 4,920 | 4,602 | 5,731 | 4,429 | 4,365 | 4,513 | 5,390 |
| Total Assets | 9,125 | 9,679 | 12,940 | 13,864 | 14,094 | 14,880 | 14,244 | 16,082 | 17,437 | 18,392 | 19,298 | 20,942 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,027 | 847 | 1,860 | 1,723 | 1,729 | 1,588 | 2,030 | 1,451 | 2,151 | 2,070 | 2,577 | 2,488 |
| Investing | -1,236 | -622 | -2,243 | -336 | 274 | -552 | -292 | -844 | -1,754 | -3,431 | -343 | 421 |
| Financing | -12 | -202 | 665 | -1,384 | -2,039 | -1,295 | -1,816 | -380 | -794 | 1,406 | -2,181 | -2,388 |
| Net Cash Flow | -221 | 23 | 282 | 3 | -36 | -259 | -79 | 227 | -398 | 45 | 52 | 522 |
| Free Cash Flow | 814 | 639 | 1,680 | 1,412 | 1,521 | 1,436 | 1,866 | 1,453 | 2,158 | 1,793 | 2,018 | 1,946 |
| CFO/OP | 93 | 71 | 119 | 102 | 102 | 90 | 101 | 79 | 105 | 83 | 101 | 95 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 48 | 41 | 46 | 46 | 43 | 33 | 33 | 34 | 40 | 47 | 44 |
| Inventory Days | 102 | 123 | 125 | 135 | 125 | 146 | 127 | 128 | 84 | 73 | 79 | 82 |
| Days Payable | 103 | 140 | 152 | 201 | 204 | 212 | 149 | 130 | 99 | 97 | 120 | 114 |
| Cash Conversion Cycle | 34 | 32 | 13 | -20 | -33 | -24 | 11 | 31 | 19 | 16 | 7 | 12 |
| Working Capital Days | -25 | -6 | -22 | -31 | -20 | -42 | -33 | -7 | -2 | -60 | -83 | -85 |
| ROCE % | 20% | 23% | 22% | 21% | 20% | 19% | 20% | 19% | 17% | 19% | 19% | 19% |
Documents
Frequently Asked Questions about Godrej Consumer Products Ltd
What does Godrej Consumer Products Ltd do?
Where is Godrej Consumer Products Ltd (GODREJCP) listed?
Which sector does Godrej Consumer Products Ltd belong to?
What is the market capitalisation of Godrej Consumer Products Ltd?
What is the PE ratio of Godrej Consumer Products Ltd?
What is the 52-week high and low of Godrej Consumer Products Ltd?
Does Godrej Consumer Products Ltd pay dividends?
What is the Return on Equity (ROE) of Godrej Consumer Products Ltd?
How can I research Godrej Consumer Products Ltd on Tapetide?
Company Information
Godrej Consumer Products is engaged in a fast moving consumer goods Company, manufacturing and marketing Household and Personal Care products.[1]